The Association for Advancing Automation (A3) released second-quarter North American robot order data on August 11, 2026, and the two headline numbers point in different directions. Companies in the United States, Canada and Mexico ordered 8,940 robots in Q2 2026 — up 4.3% from the same quarter a year earlier. Those robots were worth $622 million — up 21.3%.
Revenue grew 4.95 times faster than volume. That gap, not the growth itself, is the story in this release. And a critical scope note before anything else: A3 reports orders booked with its member vendors, not shipments or installations. These are commitments, and the lag between a booking and a robot bolted to a floor typically runs quarters, not weeks.
The price story comes first
Do the arithmetic the release invites. At 8,940 units and $622 million, the average robot ordered in Q2 2026 carried an implied price of roughly $69,575. Back out the year-ago comparison — 4.3% fewer units, 21.3% less revenue — and Q2 2025 works out to about $59,830 per machine. That is a ~16% increase in average selling price in twelve months, in a market where hardware pricing has spent most of the last decade going the other way.
The more useful check is whether this is a slow drift or a step change. A3 also reported first-half totals of 17,995 units and $1.166 billion (+2.0% units, +6.6% revenue). Subtract the quarter from the half and Q1 2026 lands at roughly 9,055 units and $544 million — an implied ASP near $60,100, essentially flat against the full-year 2025 figure of about $61,200 (36,766 units, $2.25 billion, per A3's 2025 annual release).
So the price-mix jump is a Q2 event. One quarter, roughly $9,500 added to the average machine. Operators budgeting off a rolling twelve-month average will not see this in their numbers yet.
Collaborative robots corroborate it
The obvious skeptical read is that something changed in how cheap machines get counted. The collaborative-robot line argues against that.
In Q2 2026, cobots accounted for 1,137 units and $44 million — 12.7% of units ordered and just 7.1% of order value, as Robotics & Automation News breaks out. For the first half, cobots ran 2,774 units and $114 million (15.4% of units, 9.8% of revenue). Full-year 2025 was 7,212 units and $241 million — 19.6% of units.
That is a clean downtrend: 19.6% → 15.4% → 12.7%. (Note the H1 figure of 2,774 units is a half-year number; it has been misread as a quarterly figure in some coverage, which understates how sharply the quarter moved.) Cobot share is contracting while total order value climbs. Strip the cobots out of Q2 entirely and the remaining 7,803 units carry $578 million — about $74,000 per machine.
A3 publishes no breakdown by payload class, sensing package or cleanroom rating, so any claim about what kind of machine is driving the mix is inference, not reported fact. What the data supports is narrower and still significant: buyers are committing to materially more expensive equipment per unit, and the low-cost entry tier is losing share while they do it.
What Detroit did
The demand-side split is where this release earns attention. Automotive OEM orders fell 25% in the first half of 2026 versus the first half of 2025. A3 published this as an H1-over-H1 comparison — there is no separate Q2-only OEM figure in the release, and it should not be quoted as a quarterly number.
Against that, automotive component suppliers ordered 24% more in H1 and 20% more in Q2. The supply base is buying while the assemblers are not. That divergence is the most under-covered fact in the release, and it inverts the 2025 pattern, when A3 reported component orders below 2024 levels while OEM activity improved.
The leading explanation: a retooling pause
A3 offers no causal analysis, so what follows is interpretation. But the timing lines up with a specific, verified set of program decisions in Detroit. Ford discontinued the F-150 Lightning in December 2025 and canceled both its next-generation Project T3 electric pickup and a next-generation electric commercial van. GM discontinued the BrightDrop 400 and 600 in October 2025 at its CAMI plant. Stellantis postponed the Dodge Charger Daytona R/T to 2026 and reportedly canceled the Charger Banshee. InsideEVs maintains a program-by-program record of these cancellations and delays.
Every one of those is a body shop that does not get retooled. Vehicle program launches are what generate large, lumpy welding and material-handling robot orders; canceled programs remove those orders from the pipeline without any change in an automaker's long-run automation strategy. That is a capex pause, not a structural exit — but the data alone cannot distinguish the two.
Who took the slack
Growth in Q2 came from nearly everywhere else. Semiconductors, electronics and photonics ordered 38% more than in Q2 2025. Automotive components rose 20%. Food and consumer goods and metals each rose 18%. Life sciences, pharmaceutical and biomedical orders rose 9%.
That last figure deserves an honest caveat. Life sciences ran +32% for the first half but only +9% in the quarter — the pharma surge decelerated sharply inside Q2. "Pharma is absorbing the slack" is an H1 statement, not a Q2 one.
Non-automotive customers accounted for 56% of all units ordered in Q2 2026. It is worth correcting a framing that has circulated with this number: this is not a threshold being crossed for the first time. A3's own full-year 2025 release already reported general industries taking the majority share of units. The non-automotive majority is a continuation, not a debut. The genuinely new development is the direction reversal within automotive itself — components up, OEM down, after precisely the opposite pattern a year earlier.
One more piece of backdrop: A3 cited a 1.1% year-over-year increase in manufacturing output alongside the release, per Design Engineering. A 21.3% jump in robot order value against roughly one point of output growth is not a broad capex boom. It is mix.
What this means for operators
If your automation business case was built on 2019-era arm pricing — or even on 2025's $61,200 average — the payback math is stale. A machine that costs 16% more needs either more throughput per cell or more months to clear the hurdle rate, and neither shows up until someone re-runs the numbers.
Three practical consequences:
- Re-baseline integrator quotes before the capex request, not after. The ASP move is one quarter old and will not yet be visible in trailing averages or vendor list-price sheets that lag bookings.
- The cheap-entry-point strategy is running against the market. Cobot share has fallen from 19.6% to 12.7% of units. That does not make cobots wrong for a given cell, but volume-driven pricing leverage is moving toward the higher-value tier.
- Sector matters for lead times. A3 reports cobots made up 43.7% of units ordered by life sciences and 36.5% of units ordered by semiconductor and electronics buyers. The two fastest-growing sectors are also the most cobot-heavy, which means competition for that specific supply is concentrated.
Geography: analysis, not data
The following is inference. A3 publishes no state- or metro-level breakdown, and nothing in this release supports a geographic claim.
That said, the sector mix has a physical location. Semiconductor and pharmaceutical order growth implies integrator backlog following fab and fill-finish construction rather than Midwest body-shop retooling. The named capex anchors are real: TSMC's Arizona program was announced in December 2022 at approximately $40 billion for two fabs — N4 production from 2024, 3nm from 2026 — and roughly 10,000 high-tech jobs. (Larger current figures circulate in secondary coverage and warrant separate verification.) Novo Nordisk announced $4.1 billion in June 2024 for a second fill/finish plant in Clayton, North Carolina — 1.4 million square feet, 1,000 jobs, construction completing between 2027 and 2029.
Those projects need aseptic handling, cleanroom-rated equipment and vision-guided assembly. Whether the integrator base has actually shifted its center of gravity toward Arizona and the Carolinas is a reasonable hypothesis that this dataset cannot test.
The open question
Alex Shikany, executive vice president at A3, framed the release carefully: "The first half of 2026 shows how the mix of the robotics market continues to evolve. Automotive remains an important driver of demand, while we're also seeing growth across a wider range of industries."
Note what he did not say. He did not describe automotive as dethroned, and that restraint is warranted by the data.
The question the numbers leave open is whether -25% is a capex pause tied to shelved EV programs or the start of automotive ceasing to be the demand anchor for North American robotics. The 2025-to-2026 reversal argues for a pause: a sector whose component and OEM lines swap direction in twelve months is cycling, not exiting. The ASP and cobot-mix trends argue the other way — the industry just grew order value 21% in a quarter while its historically largest customer cut back by a quarter, which is a demonstration that it no longer needs Detroit to grow revenue.
A3's Q3 2026 release is the next checkpoint. Two things to watch: whether the ~$69,600 ASP holds or reverts toward the $60,000 range that characterized Q1, and whether the automotive OEM line stabilizes. A single quarter of price-mix expansion is a data point. Two is a market.
The numbers at a glance
MetricQ2 2026H1 2026FY 2025Units ordered8,94017,99536,766Order value$622M$1.166B$2.25BUnits YoY+4.3%+2.0%+6.6%Revenue YoY+21.3%+6.6%+10.1%Implied ASP~$69,600~$64,800~$61,200Cobot units1,1372,7747,212Cobot share of units12.7%15.4%19.6%Cobot share of revenue7.1%9.8%10.7%ASP figures are derived from A3's reported unit and value totals. The 2,774-unit cobot figure is a first-half number and should not be read as quarterly.
Related reading
-
[Washington Just Banned New Foreign Mobile Robots — and the Rule Doesn't Stop at Humanoids](/article/fcc-covered-list-foreign-mobile-robots-warehouse-automation)
-
[The Biggest Memory Bet of the Cycle Isn't American: SK hynix Commits $38B to Korean Fabs While U.S. Manufacturers Absorb the Shortage](/article/sk-hynix-54-trillion-won-korean-fabs-memory-shortage-industrial-buyers)
Sources
- Q2 2026 robotics demand increased across industries, reports A3 — The Robot Report
- Robot orders increase to $622 million in Q2 as automation demand broadens across industries — Robotics & Automation News
- Robot Orders Increase In Q2: A3 — Design Engineering
- North American robot orders rise by 6.6% in 2025, reports A3 — The Robot Report
- All The EVs That Got Canceled Or Delayed In 2025 And 2026 — InsideEVs
- TSMC Announces Updates for TSMC Arizona — TSMC (December 6, 2022)
- Novo Nordisk plans $4.1B Johnston Co. expansion — North Carolina Biotechnology Center